Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
Condition(s):Melanoma (Skin)Last Updated:January 6, 2014Unknown status
Hide Studies Not Open or Pending
Condition(s):Melanoma (Skin)Last Updated:January 6, 2014Unknown status
Condition(s):Metastatic Melanoma; Stage III Melanoma; Stage IV MelanomaLast Updated:June 5, 2020Completed
Condition(s):MelanomaLast Updated:May 6, 2023Completed
Condition(s):Cancer; MelanomaLast Updated:June 8, 2015Completed
Condition(s):Melanoma Stage III or IVLast Updated:February 19, 2009Completed
Condition(s):Stage III (Unresectable) or Stage IV Advanced MelanomaLast Updated:September 29, 2016No longer available
Condition(s):Melanoma (Skin)Last Updated:January 19, 2024Completed
Condition(s):Melanoma (Skin)Last Updated:March 13, 2015Withdrawn
Condition(s):MelanomaLast Updated:August 30, 2023Active, not recruiting
Condition(s):MelanomaLast Updated:September 18, 2013Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.